Download PDF

Other users also viewed these articles

Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH¿AEG¿SEPD¿SEOM¿GETECCU Mar Riveiro-Barciela; Sabela Carballal; Álvaro Díaz-González; Míriam Mañosa; Javier Gallego-Plazas; Joaquín Cubiella; Paula Jiménez-Fonseca; María Varela; Luis Menchén; Bruno Sangro; Ana Fernández-Montes; Francisco Mesonero; Miguel Ángel Rodríguez-Gandía; Fernando Rivera; María-Carlota Londoño;
Gastroenterol Hepatol. 2024;47:401-32
Hepatic silicosis as a rare cause of granulomatous liver disease María Del Barrio; Maria Luisa Cagigal; Álvaro Díaz-González;
Gastroenterol Hepatol. 2025;48:
Artificial intelligence-assisted identification and retrieval of chronic hepatitis C patients lost to follow-up in the health area of Pontevedra and O Salnés (Spain) Pablo Parada Vázquez; Santiago Pérez-Cachafeiro; Belén Castiñeira Domínguez; Juan Manuel González-Pérez; José Manuel Mera Calviño; Raquel Souto-Rodríguez; Yolanda Falagán Cachafeiro; Indhira Pérez-Medrano; Nuria Vázquez-Temprano; Matilde Trigo; Alba Carrodeguas; José Luis González-Sánchez; Carmen Durán-Parrondo; Juan Turnes;
Gastroenterol Hepatol. 2025;48: